19-10222312-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004230.4(S1PR2):​c.*1532G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.493 in 151,832 control chromosomes in the GnomAD database, including 19,261 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 19249 hom., cov: 30)
Exomes 𝑓: 0.55 ( 12 hom. )

Consequence

S1PR2
NM_004230.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0520

Publications

33 publications found
Variant links:
Genes affected
S1PR2 (HGNC:3169): (sphingosine-1-phosphate receptor 2) This gene encodes a member of the G protein-coupled receptors, as well as the EDG family of proteins. The encoded protein is a receptor for sphingosine 1-phosphate, which participates in cell proliferation, survival, and transcriptional activation. Defects in this gene have been associated with congenital profound deafness. [provided by RefSeq, Mar 2016]
DNMT1 (HGNC:2976): (DNA methyltransferase 1) This gene encodes an enzyme that transfers methyl groups to cytosine nucleotides of genomic DNA. This protein is the major enzyme responsible for maintaining methylation patterns following DNA replication and shows a preference for hemi-methylated DNA. Methylation of DNA is an important component of mammalian epigenetic gene regulation. Aberrant methylation patterns are found in human tumors and associated with developmental abnormalities. Variation in this gene has been associated with cerebellar ataxia, deafness, and narcolepsy, and neuropathy, hereditary sensory, type IE. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNMT1 Gene-Disease associations (from GenCC):
  • autosomal dominant cerebellar ataxia, deafness and narcolepsy
    Inheritance: Unknown, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary sensory neuropathy-deafness-dementia syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.575 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004230.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
S1PR2
NM_004230.4
MANE Select
c.*1532G>A
3_prime_UTR
Exon 2 of 2NP_004221.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
S1PR2
ENST00000646641.1
MANE Select
c.*1532G>A
3_prime_UTR
Exon 2 of 2ENSP00000496438.1O95136
DNMT1
ENST00000588952.5
TSL:5
c.-401-3443G>A
intron
N/AENSP00000467050.1K7ENQ6
DNMT1
ENST00000592342.5
TSL:3
c.-284+8892G>A
intron
N/AENSP00000465993.1K7ELB1

Frequencies

GnomAD3 genomes
AF:
0.494
AC:
74858
AN:
151636
Hom.:
19255
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.386
Gnomad AMI
AF:
0.545
Gnomad AMR
AF:
0.473
Gnomad ASJ
AF:
0.638
Gnomad EAS
AF:
0.251
Gnomad SAS
AF:
0.502
Gnomad FIN
AF:
0.440
Gnomad MID
AF:
0.602
Gnomad NFE
AF:
0.580
Gnomad OTH
AF:
0.546
GnomAD4 exome
AF:
0.551
AC:
43
AN:
78
Hom.:
12
Cov.:
0
AF XY:
0.550
AC XY:
22
AN XY:
40
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.516
AC:
32
AN:
62
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.500
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.714
AC:
10
AN:
14
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.493
AC:
74872
AN:
151754
Hom.:
19249
Cov.:
30
AF XY:
0.486
AC XY:
36010
AN XY:
74148
show subpopulations
African (AFR)
AF:
0.386
AC:
15976
AN:
41394
American (AMR)
AF:
0.472
AC:
7191
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.638
AC:
2213
AN:
3470
East Asian (EAS)
AF:
0.250
AC:
1289
AN:
5146
South Asian (SAS)
AF:
0.502
AC:
2410
AN:
4800
European-Finnish (FIN)
AF:
0.440
AC:
4628
AN:
10508
Middle Eastern (MID)
AF:
0.586
AC:
171
AN:
292
European-Non Finnish (NFE)
AF:
0.580
AC:
39344
AN:
67890
Other (OTH)
AF:
0.546
AC:
1154
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1851
3702
5554
7405
9256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.564
Hom.:
50198
Bravo
AF:
0.493
Asia WGS
AF:
0.391
AC:
1362
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
6.4
DANN
Benign
0.66
PhyloP100
-0.052

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10409243; hg19: chr19-10332988; API